We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 38,838 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/4/2020 18:33 | ok thanks looks the real deal | formula1187 | |
05/4/2020 18:25 | >> formula I have sent you a PM with the emails in..... Wouldn't have a clue how to put it on YouTube and I am not on Twitter. It is really really sad that you don't believe me. Credibility on this BB is what it is all about for me..... | nobbygnome | |
05/4/2020 18:20 | hxxps://www.nottingh | royalalbert | |
05/4/2020 18:08 | Toffeeman thank you for your civil reply. | hazl | |
05/4/2020 18:01 | Grow up man. Not you Tom:) | bmnsa | |
05/4/2020 18:00 | Agree that the whole email should be shared via YouTube or Twitter so all PI’s can see for themselves. It’s sadly no surprise to me that the recovery trial ramp has been quashed, if it was happening it would have been RNS’d, and it certainly wouldn’t explicitly say on the trial homepage that it was currently excluded. IMO it’s evident that if the pilot is successful, SG016 will be included in the recovery trial, if the pilot is inconclusive then it won’t be. So it’s the same binary bet as it’s always been. Let’s hope that it is successful & is approved ASAP, but it’s not worth going all in as Likya123 / Floydymagic would encourage you to do. | 74tom | |
05/4/2020 17:38 | i want proof very easly done can you tube it | formula1187 | |
05/4/2020 17:37 | Formula No surprise to me at all RM would email a PI on a Sunday. I’ve had a CEO regularly email me on a Sunday with an AIM listed company. I think we should be thankful that Nobby shared what Richard said. | lunus1 | |
05/4/2020 17:32 | nobby what proof do you have | formula1187 | |
05/4/2020 17:26 | bit surprising to me that he would email a pi on sunday | formula1187 | |
05/4/2020 17:24 | hazl I am still in FARN I made a silly (small) investment at 800! and then held and bought more after the plummet exiting with a small profit. I still hold a small amount via Guinness AIM EIS (they bought the last fund raise) where I also hold a portfolio of stocks - some doing well and others which are utter disasters. Guiness AIM EIS was how I first learned of SNG and when they fell to 5.9p I thought it was because of Woody pressure and so I made an additional ISA purchase because I thought the price would rise after Link exited - wrong analysis but good out turn. Have a nice rest of the weekend. Yours with an aching back from weeding | toffeeman | |
05/4/2020 16:56 | >> formula Are you suggesting I made up that I got an email from Richard Marsden? Surely not... | nobbygnome | |
05/4/2020 16:50 | Anyway SNG is the important one for us. | hazl | |
05/4/2020 16:39 | She could have been right about FARN these things can go one way or the other,its just not that simple is it? | hazl | |
05/4/2020 16:36 | But you are invested here and SM has brought it to people's attention. It's also reassuring for people to know that these companies are trying to help people. Perhaps if you had stayed in FARN or quit at a height you might have been better off? | hazl | |
05/4/2020 16:34 | Sunday received email from Richard can this be correct | formula1187 | |
05/4/2020 16:33 | Thanks 141j good idea to bring attention to it, a lot of us can't wade through lots of posts. | hazl | |
05/4/2020 16:32 | The point is that newspaper journalists normally know less than those invested in a stock - and anyone who invests on their say so needs to learn a lesson (as I did with Farn!) | toffeeman | |
05/4/2020 16:30 | As discussed yesterday Leicester are taking part in SG016 which is SNG's double blind study. | nobbygnome | |
05/4/2020 16:26 | Apologies if duplicated or commonly known; Leicester research's website lists various Covid 19 trials; IASRIC ; RECOVERY ; SARS Cov-2 infection study. The latter has Synairgen's website address and is marked " STATUS - Sponsor green light;due to start recruiting 06.04.20 | 141jaffa | |
05/4/2020 16:25 | And what exactly was the point of that reminder Toffeeman? FARN has recovered a lot since then and any of these firms can have failures as well as successes! | hazl | |
05/4/2020 15:28 | Nobby, that's the most positive email I've ever seen. Not only "when" and not if but as you said "expeditious approval" It appears Richard knows this will be supplied globally, hence the recent RNS confirming the £4 million buying of sng001. "fastest cleanest route" all about getting this out to the planet as quick as practically possible! Again this is not ramping but simply joining the massive dots. 'SNG001 is only being tested in the SG016 placebo-controlled trial, when we have the results we will discuss appropriate routes to expeditious approval with regulators and other interested parties around the world. This, we believe, is the fastest cleanest route to making SNG001 globally available' | likya123 | |
05/4/2020 15:08 | Makendon Sabah Meddings - please read post 1303 pn this thread :) | toffeeman | |
05/4/2020 14:27 | Well done Nobby that's reassured me somewhat after the beating we took last week! Hoping I can buy in more Monday still unbelievable that I couldn't deposit into my Hargreaves Lansdown account Friday. | adman50 | |
05/4/2020 14:27 | Nobby - many thanks for confirming. | cfccfc1970 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions